CUAMC
AARD icon

China Universal Asset Management Company’s Aardvark Therapeutics AARD Stock Holding History

China Universal Asset Management Company’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Sell
3,472
-392
-10% -$1.83K ﹤0.01% 496
2026
Q1 		$14.6K Buy
3,864
+316
+9% +$3.28K ﹤0.01% 497
2025
Q4 		$46.6K Buy
+3,548
New +$44.3K ﹤0.01% 459

Other funds holding AARD

DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cantor Fitzgerald
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

China Universal Asset Management Company's AARD Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Aardvark Therapeutics (AARD) stake by 10% in Q2 2026, selling an estimated $1.83K and leaving 3,472 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #496.

China Universal Asset Management Company first reported a position in AARD in Q4 2025 and has held it in 3 quarters since. The position peaked at $46.6K in Q4 2025. 71 funds tracked by Wall St. Rank hold AARD as of Q2 2026.

  • China Universal Asset Management Company held 3,472 shares of Aardvark Therapeutics worth $20K as of Q2 2026.
  • China Universal Asset Management Company sold 392 Aardvark Therapeutics shares in Q2 2026, an estimated $1.83K.
  • Aardvark Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #496 holding.
  • China Universal Asset Management Company first reported a position in Aardvark Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • China Universal Asset Management Company's Aardvark Therapeutics position peaked at $46.6K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.